Diabetes and heart failure: epidemiology, pathophysiology and management

Indian Heart J. 2005 Jul-Aug;57(4):295-303.

Authors

Akshay S Desai¹, Patrick T O'Gara

Affiliation

¹ Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, USA. adesai@partners.org

PMID: 16350674

No abstract available

Publication types

Review

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Carbazoles / therapeutic use
Carvedilol
Diabetes Mellitus, Type 2 / drug therapy
Diabetes Mellitus, Type 2 / physiopathology*
Diabetes Mellitus, Type 2 / prevention & control
Diabetic Angiopathies / drug therapy*
Diabetic Angiopathies / epidemiology
Diabetic Angiopathies / physiopathology*
Diabetic Angiopathies / prevention & control
Diabetic Nephropathies / prevention & control
Humans
Mineralocorticoid Receptor Antagonists / therapeutic use
Propanolamines / therapeutic use
Spironolactone / therapeutic use

Substances

Adrenergic beta-Antagonists
Carbazoles
Mineralocorticoid Receptor Antagonists
Propanolamines
Carvedilol
Spironolactone